| J9271 | Injection, pembrolizumab, 1 mg | 10 | 10 | 90 | $6,340 | $5.2M |
| H0018 | Behavioral health; short-term residential (non-hospital residential treatment program), without room and board, per diem | 47 | 70 | 3,240 | $390 | $4.7M |
| H0019 | Behavioral health; long‑term residential (non‑medical, non‑acute care in a residential treatment program where stay is typically longer than 30 days), without room and board, per diem | 21 | 50 | 3,580 | $380 | $3.7M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 20 | 150 | 5,330 | $50 | $2.8M |
| 99285 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a high level of medical decision making. | 114 | 400 | 1,510 | $190 | $2.6M |
| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 87 | 480 | 1,350 | $110 | $1.7M |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | 11 | 10 | 440 | $970 | $1.4M |
| 99283 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a low level of medical decision making. | 71 | 450 | 1,540 | $90 | $1.3M |
| 96374 | The provider administers a single medication or other substance rapidly into a vein to treat, prevent, or diagnose a condition. | 45 | 150 | 7,610 | $90 | $1.2M |
| G0378 | Hospital observation service, per hour | 29 | 100 | 2,820 | $180 | $1.1M |